Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Anti Kickback
Dismissal in Trinity Qui Tam Suit Affirmed
In June 2020, the United States Court of Appeals for the Eighth Circuit affirmed the dismissal with prejudice of a qui tam suit…
Novartis Settlements and Corporate Integrity Agreement 2020 Version 3.0
Last week, the United States Department of Justice (DOJ) announced a $642 million settlement with Novartis over improper payments…
HHS Issues Blanket Waivers for Stark Law – Physician Self-Referral in…
The US Department of Health and Human Services (“HHS”) recently announced that it will issue blanket waivers of the Stark Law for…
Teva Settles AKS Allegations
Earlier this year, Teva agreed to pay $54 million to settle an Anti-Kickback Statute (AKS) and False Claims Act (FCA) claim that…
Kickback Suit Against Novartis for Gilenya Dismissed
In late March, a federal judge dismissed a whistleblower lawsuit against Novartis AG that accused the company of engaging in a…
Sanofi Settles False Claims Act Violation Allegations
On February 28, 2020, the United States Department of Justice (DOJ) announced that Sanofi-Aventis U.S., LLC (Sanofi) agreed to pay…
US Declines to Intervene in Orthopedic Surgeon’s FCA Whistleblower Suit
In May 2019, Florida orthopedic surgeon Ayman Daouk, MD, brought a whistleblower suit against his employer, Orlando Health, and…
HHS OIG Issues Advisory Opinion on Provider-Paid Travel for Rare Disease…
On January 21, 2020, the United States Department of Health and Human Services Office of Inspector General (HHS OIG) posted OIG…
Healthcare Providers Support Proposed Changes to Stark Self-Referral Rules
As we reported in October, the Centers for Medicare and Medicaid Services (“CMS”) and the Department of Health and Human Services…
Insys Executives’ Convictions Partially Overturned
The story of Insys Therapeutics continues to get more interesting. In the first criminal trial of pharmaceutical executives…